23-Valent Polysaccharide Vaccine (PPSV23)-Targeted Serotype-Specific Identification Of Streptococcus Pneumoniae using the Loop-Mediated Isothermal Amplification (LAMP) Method by Lee, Jiwon et al.
Wayne State University 
Department of Pharmacy Practice Eugene Applebaum College of Pharmacy and Health Sciences 
1-16-2021 
23-Valent Polysaccharide Vaccine (PPSV23)-Targeted Serotype-
Specific Identification Of Streptococcus Pneumoniae using the 











See next page for additional authors Follow this and additional works at: https://digitalcommons.wayne.edu/pharm_practice 
 Part of the Investigative Techniques Commons, and the Pharmacy and Pharmaceutical Sciences 
Commons 
Recommended Citation 
Lee J, Yoon Y, Kim EJ, Lee D, Baek Y, Takano C, et al. (2021) 23-valent polysaccharide vaccine (PPSV23)-
targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated 
isothermal amplification (LAMP) method. PLoS ONE 16(2): e0246699. https://doi.org/10.1371/
journal.pone.0246699 
This Article is brought to you for free and open access by the Eugene Applebaum College of Pharmacy and Health 
Sciences at DigitalCommons@WayneState. It has been accepted for inclusion in Department of Pharmacy Practice 
by an authorized administrator of DigitalCommons@WayneState. 
Authors 
Jiwon Lee, Youngbae Yoon, Eun Jin Kim, Donghyun Lee, Yeoungjun Baek, Chika Takano, Bin Chang, 
Takahiro Iijima, Paul E. Kilgore, Satoshi Hayakawa, Tomonori Hoshino, Dong Wook Kim, and Mitsuko Seki 
This article is available at DigitalCommons@WayneState: https://digitalcommons.wayne.edu/pharm_practice/22 
RESEARCH ARTICLE
23-valent polysaccharide vaccine (PPSV23)-
targeted serotype-specific identification of
Streptococcus pneumoniae using the loop-
mediated isothermal amplification (LAMP)
method
Jiwon Lee1,2,3☯, Youngbae Yoon1,2,3☯, Eun Jin Kim1,2,3☯, Donghyun Lee1,2,3,
Yeongjun Baek1,2,3, Chika Takano4, Bin Chang5, Takahiro Iijima1, Paul E. Kilgore6,
Satoshi Hayakawa4, Tomonori Hoshino1, Dong Wook KimID
2,3*, Mitsuko SekiID1,4*
1 Division of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School
of Dentistry, Saitama, Japan, 2 Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan,
Republic of Korea, 3 Institute of Pharmacological Research, Hanyang University, Ansan, Republic of Korea,
4 Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine,
Tokyo, Japan, 5 Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan, 6 Department of
Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University,
Detroit, MI, United States of America
☯ These authors contributed equally to this work.
* dongwook@hanyang.ac.kr (DWK); mitsuko.seki@dent.meikai-u.ac.jp (MS)
Abstract
Reports of invasive disease due to Streptococcus pneumoniae have declined since the
introduction of pneumococcal conjugate vaccines (PCV7 and PCV13). The incidence of
invasive diseases due to S. pneumoniae that are not addressed by the vaccines, however,
has increased in children and adults, creating a global public health problem. Previously, we
established the loop-mediated isothermal amplification (LAMP) method for a PCV13 sero-
type-specific assay. In the current study, we developed a rapid, simple, and cost-effective
assay to detect serotypes in the 23-valent pneumococcal polysaccharide vaccine (PPSV23)
using the LAMP method. In this study, LAMP primer sets for serotypes 2, 8, 9N, 10A, 11A,
12F, 15B, 17F, 20, 22F, and 33F of S. pneumoniae were developed. The reactivity, specific-
ity, and sensitivity of LAMP assays were determined and compared to those of conventional
PCR. The feasibility of LAMP assays in clinical application in patients with invasive pneumo-
coccal diseases was validated by defining the detection limit of the LAMP assay with bacte-
rial genomic DNA-spiked blood specimens. The specificity of each LAMP assay was
determined using 44 serotypes of pneumococcal strains. Their sensitivity was 100 copies
per reaction versus 103 to 106 copies per reaction for PCR assays. Using DNA-spiked blood
specimens, excluding the LAMP assay that targeted serotype 22F (103 copies per reaction),
the limit of detection of the LAMP assay was similar to that with purified DNA as the template
(102 copies per reaction), compared with 103 to >106 copies per reaction for PCR assays. In
conclusion, a rapid and simple LAMP-based PPSV23-targeted serotype detection assay
was developed for use in many countries. This study is the first report of a LAMP-based
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assay for identification of PPSV23 serotypes. Further evaluation of this assay is needed
through surveillance and vaccine efficacy studies.
Introduction
Pneumonia is an important infectious disease with high morbidity and mortality [1, 2]. Strep-
tococcus pneumoniae can lead to serious invasive diseases, such as meningitis, septicemia, and
pneumonia, as well as milder but more common illnesses, such as otitis media [3]. S. pneumo-
niae frequently colonizes the human nasopharynx, and infants and young children are the
main reservoir of this organism. Higher carriage rates among children in low- and middle-
income countries and immunocompromised adults in high-income countries have been
reported [4, 5]. A 23-valent polysaccharide vaccine (PPSV23) was introduced in the early
1980s, and pneumococcal conjugate vaccines (PCV7 or 13) have been available for children
younger than 5 years since 2009; at least 10 other PCVs, containing 10–20 serotypes, are
undergoing clinical trials [6]. PPSV23 contains 12 of the serotypes in PCV13 and an additional
11 serotypes (2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F). PPSV23 is recommended
for prevention of invasive pneumococcal diseases (IPDs) among all adults aged� 65 years and
in high-risk adults aged 19–64 years [5]. Administration of PCV to those older than 5 years
may be useful in control of outbreaks in older children and adults [7].
Since the introduction of PCVs, IPDs in children have decreased [8, 9]. However, non-PCV
serotype strains have become an emerging problem in high-income countries [9], and IPD-
associated mortality in adults and children remains significant in low- and middle-income
countries [10].
The capsular polysaccharide is an essential virulence factor of S. pneumoniae, and pneumo-
coccal serotypes are defined based on differences in structure. There are approximately 94
serotypes, and their dissemination varies geographically [11, 12]. Current PCVs have been
developed against the most prevalent invasive serotypes identified in surveillance studies [12].
However, after introductions of PCVs, IPDs caused by non-PCV types increased [13]. In addi-
tion, regarding the impact and cost-effectiveness of PPSV23, there are various opinions and no
consensus on use of this vaccine [14]. The WHO recommends that the epidemiological impact
of pneumococcal vaccines be carefully monitored by sustained, high-quality sentinel and pop-
ulation-based surveillance of pneumococcal disease [6].
Conventional bacterial culture of S. pneumoniae requires specialized bacterial culture
media and reagents and should be performed according to the laboratory biosafety manual
[15]. The Quellung reaction using type-specific pneumococcal antisera has been routinely
used in serological typing of pneumococci. Swelling of the bacterial capsule by type-specific
antisera is scored under a microscope in this conventional determination. However, the
method cannot be used on culture-negative samples. Additionally, the precise reactions
require advanced technical skill, and errors can occur without strict control of antisera. Accu-
rate determination of pneumococcal serotyping remains problematic in low- and middle-
income countries with limited routine microbiology laboratory services and facilities [16].
Therefore, effective serotype identification tests of S. pneumoniae that could be routinely uti-
lized are desired.
Molecular methods can be a useful alternative, and multiplex polymerase chain reaction
(PCR)-based assays for identification of serotypes of S. pneumoniae have been developed and
successfully identified pneumococcal serotypes when standard culture methods failed [17].
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Loop-mediated isothermal amplification (LAMP) is a nucleic acid amplification method useful
in diagnosis of various infectious diseases and is one of the most specific, sensitive, robust, and
easy to use molecular methods [18, 19]. Pneumococcal serotyping could be further improved
using LAMP.
Diagnosis of S. pneumoniae,Haemophilus influenzae, and Neisseria meningitidis in cerebro-
spinal fluid (CSF) using LAMP assay has been reported previously [20–23]. Furthermore,
LAMP assays for discrimination of meningococcal serogroups (A, B, C, X, Y, and W) andH.
influenzae serotypes (a, b, c, d, e, and f) have been established [20, 24, 25]. Finally, LAMP
methods to detect capsular types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F (PCV7
or PCV13 vaccine-targeted serotypes) have been developed [26]. However, there are no avail-
able LAMP methods to serotype PPSV23-targeted pneumococcus. In this study, to understand
the epidemiological impact of PPSV23, we established LAMP primer sets targeting the same
genes as in conventional multiplex PCR-based assays to detect capsular types 2, 8, 9N, 10A,
11A, 12F, 15B, 17F, 20, 22F, and 33F of S. pneumoniae [27–29].
Materials and methods
Bacterial strains
Fifty-five strains of S. pneumoniae, including serotypes that belong to PCV7, PCV13, and
PPSV23 and non-vaccine serotypes, were analyzed in this study (Table 1). The PCV7 serotypes
were 4 (SP0143), 6B (SP1489), 9V (SP2928), 14 (SP3320), 18C (SP2818), 19F (SP1118), and
23F (SP2838). Six additional serotypes in PCV13 were 1 (SP3121), 3 (SP1441), 5 (ATCC 6305),
6A (SP1567), 7F (SP3365), and 19A (SP1516). Eleven serotypes that belonged to PPSV23 in
addition to PCV13 were 2 (D39, P01-10), 8 (ATCC 6308, ASP1012), 9N (SP2700, SP1926),
10A (SP1933, SP2000), 11A/E (SP2760, SP3845), 12F (SP0113, SP3716), 15B (SP3354,
SP3850), 17F (NCTC 11904, SP3846), 20 (SP2830, SP3847), 22F (SP1854, SP3777), and 33F
(SP3201, SP3766). The non-vaccine serotypes were 6C (SP3362), 6D (SP2739), 7C (SP3285),
9L (T9233/128/68), 11D (SP0510), 12A (559/66), 13 (SP0073), 15A (SP2758), 15C (SP3343),
18B (SP1901), 22A (3405/39), 23A (SP3374), 24F (SP3193), 33A (Biehl), 34 (SP3359), 35B
(SP3357), 37 (SP2742), 38 (SP3356), 44 (Hammer), and 46 (Eddy nr. 73). Two non-pneumo-
coccal species,Haemophilus influenzae (IID984) and Neisseria meningitidis (HY0001), also
were analyzed.
Capsular type of 54 reference strains was identified by Quellung reaction using type-specific
pneumococcal antisera (Statens Serum Institute, Copenhagen, Denmark). Since serotypes 11A
and 11E could not be discriminated by Quellung reaction, strain SP2760 was indicated as sero-
type 11A/E. The P01-10 isolate was obtained from the Asian Bacterial Bank (ABB) of the Asia
Pacific Foundation for Infectious Diseases (APFID) in Korea. The T9233/128/68, 559/66,
3405/39, Biehl, Hammer, and Eddy nr. 73 isolates were obtained from Aarhus University in
Denmark.
Preparation of chromosomal DNA
Chromosomal DNA from the 55 strains was prepared using the Wizard1 Genomic DNA
Purification Kit (Promega, Fitchburg, WI, USA) per the manufacturer’s recommendations.
The concentration of chromosomal DNA was measured on a NanoDrop 1000 (Thermo Fisher
Scientific Inc., Waltham, MA, USA). The genome copy number was estimated based on the
molecular size of S. pneumoniae strain R6 (2.0 Mbp; GenBank accession number,
NC_003098). Each DNA sample was diluted to 105 DNA copies/reaction and used to evaluate
the specificity of the assays. For the detection limit study, serial 10-fold dilutions of genomic
DNA from PPSV23 serotypes (capsular types 2 (D39), 8 (ATCC6308), 9N (SP2700), 10A
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Table 1. Reactivity and specificity of the pneumococcal serotyping LAMP assay.
Vaccine Serotype No. of strains Strain ID Origin of isolate LAMP primer set
2 8 9N 10A 11A 12F 15B 17F 20 22F 33F
PCV7 4 1 SP0143 CSF - - - - - - - - - - -
6B 1 SP1489 N - - - - - - - - - - -
9V 1 SP2928 B - - - - - - - - - - -
14 1 SP3320 B - - - - - - - - - - -
18C 1 SP2818 B - - - - - - - - - - -
19F 1 SP1118 N - - - - - - - - - - -
23F 1 SP2838 N - - - - - - - - - - -
PCV13 1 1 SP3121 B - - - - - - - - - - -
3 1 SP1441 N - - - - - - - - - - -
5 1 ATCC 6305 U - - - - - - - - - - -
6A 1 SP1567 N - - - - - - - - - - -
7F 1 SP3365 B - - - - - - - - - - -
19A 1 SP1516 N - - - - - - - - - - -
PPSV23 2 2 D39, P01-10 U, U + - - - - - - - - - -
8 2 ATCC 6308, ASP1012 U, B - + - - - - - - - - -
9N 2 SP2700, SP1926 CSF, B - - + - - - - - - - -
10A 2 SP1933, SP2000 N, N - - - + - - - - - - -
11A 2 SP2760, SP3845 S, RT - - - - + - - - - - -
12F 2 KSP0113, SP3716 B, RT - - - - - + - - - - -
15B 2 SP3354, SP3850 RT, RT - - - - - - + - - - -
17F 2 NCTC 11904, SP3846 U, RT - - - - - - - + - - -
20 2 SP2830, SP3847 RT, RT - - - - - - - - + - -
22F 2 SP1854, SP3777 RT, RT - - - - - - - - - + -
33F 2 SP3201, SP3766 RT, RT - - - - - - - - - - +
Non-vaccine serotype 6C 1 SP3362 N - - - - - - - - - - -
6D 1 SP2739 N - - - - - - - - - - -
7C 1 SP3285 N - - - - - - - - - - -
9L 1 T9233/128/68 U - - + - - - - - - - -
11D 1 SP510 RT - - - - + - - - - - -
12A 1 559/66 U - - - - - + - - - - -
13 1 SP0073 N - - - - - - - - - - -
15A 1 SP2758 RT - - - - - - - - - - -
15C 1 SP3343 RT - - - - - - + - - - -
18B 1 SP1901 N - - - - - - - - - - -
22A 1 3405/39 U - - - - - - - - - + -
23A 1 SP3374 N - - - - - - - - - - -
24F 1 SP3193 N - - - - - - - - - - -
33A 1 Biehl U - - - - - - - - - - +
34 1 SP3359 N - - - - - - - - - - -
35B 1 SP3357 N - - - - - - - - - - -
37 1 SP2742 N - - - - - - - - - - +
38 1 SP3356 N - - - - - - - - - - -
44 1 Hammer U - - - - - + - - - - -
46 1 Eddy nr. 73 U - - - - - + - - - - -
Non-pneumococcal species
Haemophilus influenzae IID984 - - - - - - - - - - -
(Continued)
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(SP1933), 11A (SP2760), 12F (SP0113), 15B (SP3354), 17F (NCTC11904), 20 (SP2830), 22F
(SP1854), and 33F (SP3201)) were amplified by LAMP, after which we compared the results
with those of conventional PCR [27–30]. To determine the detection limit, duplicate LAMP
testing of S. pneumoniae was carried out using serial 10-fold dilutions of chromosomal DNA
over a 2-day period by two technicians. Ten-fold dilutions of each serotype of S. pneumoniae
genomic DNA were amplified using the established LAMP and conventional PCR assays [27–
30].
LAMP primer design
Eleven LAMP primer sets for S. pneumoniae were designed based on the published sequences
in GenBank and using LAMP primer design software (Table 2) [31]. A LAMP primer set con-
sisted of 2 outer primers (F3 and B3), 1 forward inner primer (FIP), 1 backward inner primer
(BIP), and loop primers (LF and/or LB).
LAMP reaction
The LAMP procedure has been described previously [25]. Briefly, we performed LAMP in a
reaction mixture consisting of 1.6 μM each of FIP and BIP, 0.2 μM each of F3 and B3, 0.4 μM
of LF/LB, 8 U of BstDNA polymerase large fragment (New England Biolabs, Ipswich, MA,
USA), 1.4 mM deoxynucleoside triphosphates, 0.8 M betaine (Sigma, St. Louis, MO, USA), 20
mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 8 mM MgSO4, 0.1% Tween 20, and
template DNA. The final volume was adjusted to 25 μL with distilled water. We incubated
each reaction mixture at 63˚C (serotypes 2, 9N, 10A, 11A, 15B, 17F, 20, 22F, and 33F), 64˚C
(serotype 8), or 65˚C (serotype 12F) for 60 minutes and then heated it at 80˚C for 2 minutes to
terminate the reaction.
Analysis of LAMP products
The turbidity of the reaction tube was determined in real time by optical density at 650 nm
(OD650) in 6-s intervals using 2 Loopamp
1 real-time turbidimeters (LA-500 and LA-200;
Eiken Chemical Co., Tokyo, Japan). We calculated the amplification time required to exceed a
turbidity of 0.1 (Tt) using turbidimeter software, as described [32].
Each amplified LAMP product was sequenced at the Akita Prefectural University Biotech-
nology Centre using the BigDye1 Terminator V3.1 cycle sequencing kit (Applied Biosystems,
Foster City, CA, USA) on a 3130xL Genetic Analyser (Applied Biosystems), and their
sequences were verified using the primers in S1 Fig.
We also tried to measure the detection using a colorimetric visual inspection dye (leucotri-
phenylmethane [33]; D-QUICK, Kaneka Co., Osaka, Japan) on an in-house DNA chip and
mobile software. The color change on the DNA chip was examined using the mobile
application.
Table 1. (Continued)
Vaccine Serotype No. of strains Strain ID Origin of isolate LAMP primer set
2 8 9N 10A 11A 12F 15B 17F 20 22F 33F
Neisseria meningitidis HY0001 - - - - - - - - - - -
a CSF, cerebrospinal fluid; N, nasopharyngeal swab; B, blood; RT, respiratory tract specimen; S, sputum; U, unknown.
b +, amplification after a 60 min incubation; -, no amplification after a 60 min incubation.
https://doi.org/10.1371/journal.pone.0246699.t001
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Table 2. LAMP primer sequences in this study.
Primer
name
LAMP primer sequence (sequence 5’-3’) Length (base
pairs)




2_F3 GGT TTT ACT GCT ATT TTT GG 20 wzy/ CR931633/ 2 63˚C
2_B3 CTA AAT TTA ACA CTC GGT TCT 21
2_FIP CAT CGT TTG TAT CCA TTT AAC TGC ATG CAA CAT TTC AAT CTT
ATG GT
47
2_BIP TCC CAG TTC AAT ATT TCT CCA CTA CAT GGG ATA ACA ATT ACC
AA
44
2_LB GCA TAT GTT TTG TTA CTA GC 20
8_F3 TTG GCA TTT CAA TTT TAT CCT TC 23 wzy/ CR931644/ 8 64˚C
8_B3 AAT AAG ACT GAT AAG ATA AGT AGC C 25
8_FIP GAC CCC AGA ATG TAT AAC CAA AAA AGT TAT TGA TAA TAT CCT
GAC TGG ACG
51
8_BIP GTT TGG GAT CCT ATT TGG GGA TTG CCA GCA TTA CTC ATC A 40
8_LF GTT CTT GCG TAT GCA GCT 18
8_LB ACT AGT TTC ACT TTT GAT TCG TT 23
9N_F3 GAA TAT GGT ATC GTA GCA GTA G 22 wzx/ CR931647/ 9N, 9L 63˚C
9N_B3 ACA CAA AGA CCT AAA AGC GG 20
9N_FIP TGC TGA TTA AAT CTG ACT TAT TCA GTT TCA AAT GTT AGC AGA
TTC AGG
48
9N_BIP AGT GGA ATC GTA CTT TCT TGT ATT TAC TAA CAT AAA TAG TTT
CGC CGT
48
9N_LF TTT GAA CAA TAG CAG GTC CT 20
9N_LB GGA TAT CCT ATG GGG GTG TT 20
10A_F3 CTG TTG GAT TAT AAG GAA CAT GA 23 wcrG/ CR931649/ 10A 63˚C
10A_B3 CAC CTG ATA ACA AAT GGA ACA T 22
10A_FIP ACT GGA CTT AAG CGA AGT AAT TGT TTT TAT TAT TGT AGG CAG
CAA AG
47
10A_BIP TGT CAT TCT CGT AGA TAG AGT TCC TAT GCA TAA CGA AAT CCT
AAC ATC
48
10A_LF AGA CTC CCC CAC ATT 15
10A_LB TGG GGA AAT TAT TCA CTA AG 20
11A_F3 GAA GGA AGA TAT CTG TTG TAA CT 23 wzy/ CR931653/ 11A, 11D 63˚C
11A_B3 CAA CTT CTC CCA ATT TCT GC 20
11A_FIP GGT ATC GAC CAT TAA AAG TAA AAT CTC TGT TGT GAT GTT AGC
ATT AG
47
11A_BIP TGG CGC ATT GTG TAT GCT AAC GGA AGT TTA AAT TGA AAG CC 41
11A_LF CTA AGA TAT GGT AAA AAA TAT CCA 24
11A_LB CCA TTC TTC AAG TGA AAT GGT TTG 24
12F_F3 ACA CCA TAT GAC TCC TTC T 19 mnaB/ CR931660/ 12F, 12A, 44,
46
65˚C
12F_B3 CCC TGG AAT AAT ACG TTC TG 20
12F_FIP CGG TCG ATT CAA TAA TAA TAA CCG CGC TAT GTG ATT GAA GCT
ACG
45
12F_BIP ATC ACC AGG AAC GGT TGA TAA ATG GAC AAG ATG AAT ATC ACT
ACC
45
12F_LF GCA ATT ATC AAG TAC CGT T 19
12F_LB TTA TTC GAC CTG TTG TAG A 19
(Continued)
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PCR assay
PCR was performed in 25-μL reaction mixtures, containing 1 U Ex Taq DNA polymerase
(TaKaRa Bio, Tokyo, Japan), 0.2 mM of each deoxyribonucleoside triphosphate, 10 mM Tris-
HCl buffer (pH 8.3), 50 mM KCl, 2 mM MgCl2, 0.5 μM of each primer, and 2 μL of template
DNA, on a SimpliAmpTM Thermal Cycler (Applied Biosystems, Foster City, CA, USA). The
program comprised 35 cycles of denaturation at 94˚C for 30 s, primer annealing at 54˚C for 90
s, and extension at 72˚C for 60 s, with a final incubation at 72˚C for 10 minutes [27–29]. Previ-




LAMP primer sequence (sequence 5’-3’) Length (base
pairs)




15B_F3 CTA TGT TCA AAG AGG CGC 18 wzy/ CR931665/ 15B, 15C 63˚C
15B_B3 AAG CAA GAA TAG TTA CTT GTG TA 23
15B_FIP CGT AAC TGG TAG CTG ATA CGA ATC AAT GTA GTA TTG TTT GGA
AG
44
15B_BIP TGC AGG ATT TTT AGA ATA TTC AAC AAG TTT AAA TAA CCT AAT
TAA CGG
48
15B_LF CGT CCC AAC CTA ATA AGC 18
15B_LB TAA ATG GGC AGT TGA TTC 18
17F_F3 GAA TTA TTT GAA ATC TTA CCC CTC 24 wciP/ CR931670/ 17F 63˚C
17F_B3 GCT AAT TCA TCA ATT TTC GAG AT 23
17F_FIP CTT TCA ATG CAG CAA TTT TTG TTG TCT TCC ATG TTA TGC TCC
AGA
45
17F_BIP AGA CGA TAT GGG CAT AAT GTT ACA AGT TTT AAG ATT CGC TTC
AAT GT
47
17F_LF CAT GTG ATA GGA AGG C 16
20_F3 GAT AAG GTC TAC TTT GTG GGA 21 wciL/ CR931679/ 20 63˚C
20_B3 CTT CAC TTT CCT TCA ATG GAT 21
20_FIP TCC TAA ACC TTC AAA ATT AGA CGG AGT TCA GTC GAA TAT ATC
AGA ATG G
49
20_BIP CTG CAT TAG AGG CTC AAG TAA ATG GTG ATT TTT ACT TCC TTT
GGT ACA
48
20_LF AGA ATA AGT CAA AAG TAC TC 20
20_LB CCG ACA CTA CTC TCA GA 17
22F_F3 GGA TGA GGG TAA TAT TGT TGA 21 wcwV/ CR931682/ 22F, 22A 63˚C
22F_B3 CTT GAA TCA GTG TCT CTC CT 20
22F_FIP TGG GTA AAT AAA TTG AAG CTG AGA GAC TAT TCA CGG TTT AAA
GAT GA
47
22F_BIP TTG TGC TCC CGT CGA TTC AAA ACA GAC AAC TTA AAA TAC ATT
GCC
45
22F_LF TCT TTA AAT AAG GTT GAT AA 20
22F_LB TTG GTA TGG TAT TAC TTG A 19
33F_F3 CCC CAA CGG TTT ATG TGT T 19 wzy/ CR931702/ 33F, 33A, 37 63˚C
33F_B3 TCC AAG TTG TGA AAT TCC ATT 21
33F_FIP CGC CCC CAA AAT CTC TAT TTT TTG TGT GGG GGA ATA GTA GAA
GG
44
33F_BIP ACG GGG ATT TTT GCT GAA GCA GTT TGA AAT ATC AAT GCA AGG
C
43
33F_LF GCT TCA AAA TGA AGA TTA TAG TAC 24
33F_LB CCT ATG TGG AGT TTG GTA TTG 21
https://doi.org/10.1371/journal.pone.0246699.t002
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11A, 12F, 15B, 17F, 20, 22F, and 33F [27] (S1 Table). The PCR products were electrophoresed
on agarose gels and visualized with Midori Green Advance (NIPPON Genetics, Tokyo, Japan).
DNA-spiked clinical blood specimens
Pneumococcal serotypes often are examined using blood samples, as they can be collected
non-invasively, and a positive result indicates an IPD [34]. Blood was collected from 5 healthy
volunteers and heparinized for storage. Using the Procedure for Ultra Rapid Extraction
(PURE; Eiken Chemical, Tokyo), DNA from the blood samples was prepared and used for
DNA-spiked blood experiments.
Ethical declaration
We received written informed consent prior to collecting blood from 5 healthy volunteers.
The procedures were approved by the IRB of Nihon University School of Medicine (IRB No.
28-9-5). All experiments were performed in accordance with the relevant guidelines and
regulations.
Results
Analytical reactivity and specificity of LAMP-based pneumococcal
serotyping
We established LAMP primer sets targeting the same genes as in successful conventional mul-
tiplex PCR-based assays [27–29]. The LAMP primer sets for capsular types 2, 8, 9N, 10A, 11A,
12F, 15B, 17F, 20, 22F, and 33F (Table 2) successfully amplified the target DNA sequence of
each target locus (Table 1). We evaluated the analytical reactivity and specificity of LAMP-
based pneumococcal serotyping using two non-pneumococcal species and 55 pneumococcal
strains that belonged to 44 pneumococcal serotypes (Table 1). For each strain, a genomic DNA
concentration of 105 copies per reaction was used as a standard. No LAMP primer set ampli-
fied DNA of the two non-pneumococcal species. LAMP primer sets for capsular types 2, 8,
10A, 17F, and 20, which are single-serotype serogroups, did not generate any amplicon from
the DNA of other target capsular types.
The LAMP primer set for capsular type 9N also amplified the DNA of capsular type 9L.
DNA of other capsular types, including 9V, was not amplified. The pneumococcal capsular
polysaccharide (CPS) genes of serogroup 9 could be grouped into 2 clusters based on sequence
similarity; 9A and 9V had similar sequences [35], and 9N and 9L shared homologous
sequences [36]. The flippase genes (wzx) of capsular types 9N and 9L, which were targeted for
the LAMP reaction, had identical sequences and were detected by LAMP reaction. The DNA
sequence of serotype 9V, which is included in PCV7, differed from serotypes 9L and 9N; thus,
serotype 9V was not detected by the LAMP reaction for serotype 9N.
The LAMP primer set for capsular type 11A amplified DNA of capsular type 11D because
these types have the same sequence for the oligosaccharide repeat unit polymerase (wzy) gene
[36]. The DNA of other capsular types was not amplified.
Regarding the target gene of the conventional PCR primer set for capsular type 12F, Pai
et al. [27] described wzx as the target gene. However, we confirmed they actually used the
UDP-N-acetylmannosamine dehydrogenase MnaB (mnaB) gene as the target. Thus, in this
study, we designed a LAMP primer set for 12F targeting of themnaB gene. The LAMP primer
set for capsular type 12F amplified DNA of capsular types 12A, 44, and 46 as they all have the
same sequence for themnaB gene. DNA of other capsular types was not amplified [36].
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The LAMP primer set for capsular type 15B amplified DNA of capsular types 15B and 15C.
DNA of other capsular types, including 15A, was not amplified. Capsular types 15B and 15C
have the same sequence for the serotype 15B/15C-specific wzy gene, but the genes of 15A and
15F belong to a different wzy homolog group [36].
The LAMP primer set for capsular type 22F, targeting the wcwV gene of serotype 22F,
detected capsular types 22A and 22F. DNA of other capsular types was not detected by this
primer set. Capsular types 22A and 22F have the same sequence for the putative glycosyl trans-
ferase (wcwV) gene [36].
The LAMP primer set for capsular type 33F, targeting the wzy gene of serotype 33F,
detected capsular types 33A, 33F, and 37. DNA of other capsular types was not detected by this
primer set. Capsular types 33A, 33F, and 37 have the same sequence for the wzy gene.
Conventional multiplex PCR-based assays are not able to differentiate capsular types 9N,
11A, 12F, 22F, and 33F from their related pneumococcal serotypes because the same target
genes are used by the LAMP and multiplex PCR assays. Here, the Quellung reaction can dis-
criminate serotypes 9N, 11A, 12F, 22F, and 33F from their related pneumococcal serotypes.
This is a limitation of the two molecular serotyping assays.
Amplified LAMP products were subjected to DNA sequencing to verify the specificity of
the reaction (between F1 and B1; S1 Fig), and all LAMP assays produced serotype-specific
products (S2 Fig).
Detection limit of LAMP-based pneumococcal serotyping method
The detection limit of the LAMP assay was 100 genome copies per reaction. The detection
limit of the PCR assay was 103 genome copies per reaction for capsular types 8, 9N, 11A, 15B,
and 33F; 104 genome copies per reaction for capsular types 10A, 17F, and 20; 105 genome cop-
ies per reaction for capsular type 12F; and 106 genome copies per reaction for capsular type
22F (Table 3). The sensitivity of the LAMP assay was 10- to 10,000-fold greater than that of
PCR-based pneumococcal serotyping. The products were inspected visually by monitoring the
turbidity of the reaction reagent by real-time turbidimetry (S3 Fig). The detection limits of ser-
otyping LAMP assays were identical for real-time measurement and direct visual inspection.
Table 3. Detection limits of LAMP and PCR assays for DNAs of pneumococcal serotypes and using DNA-spiked blood specimens.
S. pneumoniae Detection limit (Purified DNA) Detection limit (DNA-spiked blood)
serotypes PCRa,b LAMPa PCR LAMP
2 104 copiesc 102 copies 104 copies 102 copies
8 103 102 103 102
9N 103 102 104 102
10A 104 102 106 102
11A 103 102 104 102
12F 105 102 106 102
15B 103 102 105 102
17F 104 102 106 102
20 104 102 104 102
22F 106 102 >106 103
33F 103 102 103 102
a PCR results were obtained by electrophoretic analysis. LAMP results were determined visually.
b Conventional PCR (serotypes 2 and 8 [28]; serotype 9N [29]; serotypes 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F [27]).
c Number of genome copies per reaction.
https://doi.org/10.1371/journal.pone.0246699.t003
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No LAMP amplification was detected in control samples that lacked target DNA. The experi-
ments were repeated in duplicate over 2 days, and identical results were obtained by 2
individuals.
LAMP analysis of DNA-spiked specimens
Using DNA-spiked blood specimens, 2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, and 33F were
detected by LAMP assay with sensitivity as high as when using purified DNA as the template.
The detection limit of the LAMP assay for serotype 22F decreased slightly from 100 copies to
103 copies (Table 3).
The detection limits of the PCR-based pneumococcal serotyping assay for serotypes 2, 8,
20, and 33F were the same as when using purified DNA as the template. The detection limits
for serotypes 9N and 11A decreased from 103 to 104 genome copies per reaction, and those for
serotypes 10A and 17F decreased from 104 to 106 genome copies per reaction. The detection
limit for serotype 12F declined from 105 to 106 genome copies per reaction, that for serotype
15B decreased from 103 to 105 genome copies per reaction, and that for serotype 22F decreased
from 106 to>106 genome copies per reaction.
LAMP assay using colorimetric dye and mobile software
The results of the LAMP assay using a colorimetric dye and mobile software are shown in Fig
1. A color change in LAMP reagents was observed and successfully noted by the mobile
Fig 1. Flow chart of the LAMP assay using colorimetric visual inspection dye and mobile software. The color change of the LAMP reagents was observed and noted
by the mobile software. (A) The color change of the LAMP reagents was observed and noted by the mobile software. (B) Target capsular types on the chip were as
follows: 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 7F, 19A, S. pneumoniae lytA gene as a positive control [21], 2, 6A (N/A)�, 8, 9, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F in
numerical order. �, the primer set for capsular type 6A is under development.
https://doi.org/10.1371/journal.pone.0246699.g001
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software. The DNA chip and mobile software performed multiple and simultaneous LAMP
detection of PPSV23, representing a novel advance for multiple and simultaneous LAMP
detection.
Discussion
PCVs have been introduced into the national immunization programs of most countries, and
recent estimates suggest that approximately 100,000 deaths are prevented annually around the
world [7]. The impact of PCVs on reducing antimicrobial-resistant pneumococcal strains has
been reported [7, 13, 37]. Following PCV7 or 13 vaccination programs, diseases caused by S.
pneumoniae serotypes that were not included in the vaccines (such as serotypes 8, 11A, 15A,
15B/C, 22F, 23A, 23B, and 24F) have been increasing in incidence [9, 38]. Japan experienced
invasive pneumococcal diseases caused by serotypes 15A, 24F, and 35B, which are not targeted
by the vaccine [39–41]. Approximately 80% to 90% of serotypes 35B and 15A are not suscepti-
ble to penicillin. The increased prevalence of non-vaccine serotypes that are highly non-sus-
ceptible to penicillin is a concern. The incidence of invasive pneumococcal serotype-specific
disease should be monitored, and clinical and epidemiological characteristics must be
understood.
Despite its importance, information on the burden of pneumococcal disease is limited,
especially regarding the disease in older children and adults in low- and middle-income coun-
tries. Effective and easily accessible serotype identification tests are needed to ensure the
impact of PCVs/PPSV23 and emergence of non-vaccine serotypes.
The Quellung reaction is the conventional serological typing method for pneumococcus,
but its use is limited, especially in low- and middle-income countries [16]. Multiplex PCR-
based assays for pneumococcal serotyping successfully identified pneumococcal serotyping
but requires special equipment (thermocyclers/electrophoresis) and personnel to perform
PCR assays. In addition, PCR results can be unclear.
The principle of LAMP is similar to that of PCR but uses a DNA polymerase with high
strand displacement activity (BstDNA polymerase). Thus, unlike in PCR, a DNA denaturation
step is not needed in LAMP. LAMP amplification can occur at constant temperature (60–
65˚C); LAMP does not require a thermal cycler and the reaction can be verified by observation
of the reaction mixture (no need for electrophoresis). While two primer regions are used by
PCR, four types of LAMP primers covering six primer regions are used, two inner (FIP and
BIP) and two outer primers (F3 and B3). Thus, the assay is extremely specific. Two loop prim-
ers can be added to accelerate the amplification reaction, generating 109 times amplified prod-
ucts within 1 hour. The DNA sample preparation can be simplified because of the reaction
robustness on LAMP. Due to high specificity, sensitivity, and robustness of the reaction,
LAMP is more suitable for low-resource settings and field conditions than is PCR [42].
In this study, LAMP assays to discriminate 11 serotypes (2, 8, 9N, 10A, 11A, 12F, 15B, 17F,
20, 22F, and 33F) of S. pneumoniae in PPSV23 were established. The reaction specificity and
sensitivity were validated under standard laboratory conditions, and the LAMP reactions were
evaluated in clinical specimens to ensure the effectiveness of the assays in clinical application.
The established LAMP assays performed better than PCR-based assays. The LAMP assays
were 10–104 times more sensitive than conventional PCR with purified DNA as a template,
consistent with previous studies [20–22, 24].
To examine clinical application of the pneumococcal serotyping LAMP assay, we evaluated
the sensitivity of the method using DNA-spiked blood specimens as a template. The pneumo-
coccal serotype-specific LAMP reaction had nearly equal sensitivity with DNA-spiked blood
samples when using purified DNA as a template. While PCR was inhibited by substances in
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the blood, such as heparin and other blood components, including heme, leukocyte DNA, and
immunoglobulin G, LAMP reactions were not inhibited or were inhibited only slightly when
using DNA-spiked blood [43]. The LAMP assay can be performed using simple DNA prepara-
tion methods and tolerates potentially disruptive biological elements (e.g., reaction inhibitors)
better than PCR [44, 45].
LAMP reactions have been performed individually for each target, and the increase of tur-
bidity of the reaction tube was used as the indication of positive results. However, the LAMP
method is remarkably effective when combined with the DNA-chip technique, and the LAMP
reaction chip allows multiplex and simultaneous detection [42, 46]. PCR requires thermocy-
cling that induces processes such as evaporation and droplet collision and fusion on the chip.
Thus, PCR, unlike LAMP, is not easy to apply in a DNA-chip and requires complex workflows
and multiple separate devices and instruments [47]. Moreover, LAMP has potentially better
specificity than PCR because of the use of multiple primer sets for the target sequences. False
positives can be decreased compared to the PCR method.
In this study, LAMP products were observed by a color change, from colorless to violet, due
to triphenylmethane dye, which binds double-stranded DNA (D-QUICK; Kaneka Co., Osaka,
Japan), indicating a positive reaction [33]. The newly created mobile and original code tech-
nology recognizes the positive reaction on the chip. As shown in Fig 1, color changes on the
DNA chip can be observed simultaneously, like the QR coding system of a mobile phone.
These mobile phone technologies are a critical platform for improving access in low- and mid-
dle-income countries, and the coding system (e.g., bar-coding or QR coding) can run on exist-
ing phones globally. Such mobile phone software applications would enable rapid reporting of
the test results and contribute to disease control measures.
Neither LAMP nor conventional PCR-based assays can differentiate capsular types 9N,
11A, 12F, 22F, and 33F from their related pneumococcal serotypes because the two assays use
the same target genes. On the other hand, the Quellung reaction can discriminate all of these.
This is the limitation of the two molecular serotyping assays.
This study is the first report of a LAMP-based PPSV23 serotype-specific identification assay.
The rapid and simple PPSV23-targeted serotype detection assay can be used in many countries.
We are preparing further LAMP-based methods for non-vaccine-type targets. This study reports
progress in development of LAMP-based methods that cover all pneumococcal serotypes.
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